Find your next paid study

Brainlab AGNCT07468370

Mohs Micrographic SurgeryCutaneous MalignancyMohs Surgical Defect

A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standar…

BioLab HoldingsNCT07695389

~$10 – $7,500

Surgical Site InfectionSkin CancerWound Healing

A Prospective Randomized Study of Surgical Site Infection After Linear Repair With or Without Cyanoacrylate Skin Adhesive Following Mohs Micrographic Surgery and Wide Local Excision

This study will compare surgical site infection after linear repair with or without cyanoacrylate skin adhesive following Mohs micrographic surgery or wide loc…

University of MinnesotaNCT07844681

~$10 – $6,250

Chronic Postsurgical Pain in Cerebral Palsy

The study purpose is to document the typical trajectory of perioperative pain experience in Cerebral Palsy (CP) and to identify important predictive factors fo…

Cerebral PalsyChronic Post Surgical Pain

Chantel BurkittNCT05764681

~$10 – $1,125

Blood Loss, SurgicalPostoperative Hemorrhage

Feasibility Evaluation of a Strap-Based Wearable Optical Device (Hemorai Vysio) for Monitoring Hemodynamic Trends and Early Indicators of Blood Loss in Perioperative and Postoperative Patients

The goal of this clinical trial is to learn whether the Hemorai Vysio wearable device can be used safely and feasibly to track relative changes over time in ti…

Cardiac Rhythm DisordersUrological DisordersNeurological Disorders+13 more

~$10 – $8,750

Hemorai IncNCT07826637

Medtronic Product Surveillance Registry

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The R…

~$10 – $1,125

MedtronicNCT01524276

Evaluation of the Clinical Performance of the Quantra System With the QPlus Cartridge in Pediatric Patients Undergoing Cardiovascular Procedures

This study will evaluate the performance of the Quantra System with the QPlus Cartridge in pediatric patients undergoing cardiovascular procedures.

Blood Loss, Surgical

HemoSonics LLCNCT07597278

PRECISE: A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and l…

Open SurgeryLymphedemaFree Tissue Transfer+2 more

MMI (Medical Microinstruments, Inc.)NCT06725030

Post-Market Assessment of the Incidence and Severity of Internal Hernia and Bowel Obstruction at One Year Following Use of the MagDI System to Create Side-to-Side Duodeno-Ileal Magnetic Compression Anastomoses (MagDI US Registry)

Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to…

Anastomosis, SurgicalInternal HerniaBowel Obstruction

GT Metabolic Solutions, Inc.NCT06928545

Phase 1

Zinc Oxide Versus Petrolatum Following Skin Surgery: A Head-to-head, Prospective, Split-scar Study

Patients undergoing routine surgery in the Department of Dermatology for any indication on non-scalp skin and closed in linear fashion with scar greater than o…

Surgical IncisionSurgery--ComplicationsSurgical Wound+3 more

Melissa Pugliano-MauroNCT03561376

~$10 – $7,500

Post Surgical Respiratory FailureRespiratory ComplicationOpioid Induced Respiratory Depression+1 more

Clinical Evaluation of an Alarm Activated Detection System to Enable Early Intervention of Emerging Respiratory Decline With the Linshom Medical Continuous Predictive Respiratory Sensor (CPRS)

Investigators will enroll 493 patients who will undergo non-cardiac surgery, receive supplemental oxygen via face mask or nasal cannula, and will be on continu…

Linshom Medical, Inc.NCT07793981

~$10 – $8,750

Phase 3

A Phase 3 Prospective Randomised Clinical Trial of VMX-C001 vs Usual Pharmacological Care in Patients Receiving a FXa Direct Oral Anticoagulant (FXa DOAC) Who Require Urgent Surgery or Other Invasive Procedure That is Associated With a High Risk of Bleeding, With or Without Planned Administration of Heparin (EQUILIBRIX-S)

The goal of this clinical trial is to learn if VMX-C001 works to to allow blood clotting control in participants who take FXa Direct Oral Anticoagulants (DOACs…

Blood Loss, SurgicalCoagulation Disorder